Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency

被引:21
作者
de Koning, TJ
Nikkels, PGJ
Dorland, L
Bekhof, J
De Schrijver, JEAR
van Hattum, J
van Diggelen, OP
Duran, M
Barger, R
Poll-The, BT
机构
[1] Univ Childrens Hosp Het Wilhelmina Kinderziekenhu, Dept Metab Dis, NL-3508 AB Utrecht, Netherlands
[2] Univ Childrens Hosp Het Wilhelmina Kinderziekenhu, Dept Gastroenterol, NL-3508 AB Utrecht, Netherlands
[3] Univ Utrecht Hosp, Dept Pathol, Utrecht, Netherlands
[4] Univ Utrecht Hosp, Dept Gastroenterol, Utrecht, Netherlands
[5] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 2000年 / 437卷 / 01期
关键词
congenital hepatic fibrosis; CDG syndrome; phosphomannose isomerase deficiency;
D O I
10.1007/s004280000185
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Congenital hepatic fibrosis is a rare disorder of intrahepatic bile ducts with the persistence of embryological bile duct structures in ductal plate configuration. Three siblings aged 18, 17 and 14 years old were found to have congenital hepatic fibrosis associated with a deficiency of the enzyme phosphomannose isomerase. The clinical symptoms were recurrent attacks of persistent vomiting with diarrhea and mild hepatomegaly. The biochemical abnormalities included elevated serum transferases during attacks, clotting factor deficiencies and persistent hypoalbuminemia. In the youngest patient protein-losing enteropathy was present. Liver biopsies of the three patients taken when they were 1, 3 and 14 years old showed an excess of bile duct structures in ductal plate configuration with mild fibrosis in the portal triads. In one patient the liver biopsy was repeated after 18 years and showed only a mild progression of fibrosis in the portal triads. Duodenal biopsies taken in infancy in two of the three patients did not show any abnormalities. Recognition of phosphomannose isomerase deficiency in association with congenital hepatic fibrosis and protein-losing enteropathy is important, because some of the clinical symptoms are potentially treatable by oral mannose therapy.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 26 条
[1]   CONGENITAL HEPATIC-FIBROSIS IN CHILDREN [J].
ALVAREZ, F ;
BERNARD, O ;
BRUNELLE, F ;
HADCHOUEL, M ;
LEBLANC, A ;
ODIEVRE, M ;
ALAGILLE, D .
JOURNAL OF PEDIATRICS, 1981, 99 (03) :370-375
[2]  
AVERBACK P, 1977, ARCH PATHOL LAB MED, V101, P260
[3]  
Blankenberg T A, 1991, Perspect Pediatr Pathol, V14, P143
[4]   EXPRESSION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN FETAL AND ADULT LIVER - CHANGES IN LIVER-DISEASE [J].
BURT, AD ;
STEWART, JA ;
AITCHISON, M ;
MACSWEEN, RNM .
JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (07) :719-724
[5]  
CHOU CF, 1992, J BIOL CHEM, V267, P3901
[6]  
CONRADI N, 1991, ACTA PAEDIATR SC S, V375, P50
[7]   A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency [J].
de Koning, TJ ;
Dorland, L ;
van Diggelen, OP ;
Boonman, AMC ;
de Jong, GJ ;
van Noort, WL ;
De Schryver, J ;
Duran, M ;
van den Berg, IET ;
Gerwig, GJ ;
Berger, R ;
Poll-The, BT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (01) :38-42
[8]  
de Lonlay P., 1998, Journal of Inherited Metabolic Disease, V21, P96
[9]   CYTOKERATINS FOR PROBING CELL LINEAGE RELATIONSHIPS IN DEVELOPING LIVER [J].
DESMET, VJ ;
VANEYKEN, P ;
SCIOT, R .
HEPATOLOGY, 1990, 12 (05) :1249-1251
[10]  
DESMET VJ, 1992, HISTOPATHOLOGY, V20, P465